REGENXBIO Inc.
NASDAQ:RGNXBiotechnology
Healthcare
$7.24 +1.97%
+$0.16 today
- Market cap
- $478.73M
- Beta
- 1.03
- P/E (TTM)
- -1.5
- EPS (TTM)
- -$5.53
52W Low $5.46High $16.19
Volume 0.96M
Average 1.24M
Price history
REGENXBIO Inc. SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
-35.64%
Period high
$15.98
Period low
$5.65
Latest
$7.24
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| SC 13G | Nov 10, 2026 | Nov 10, 2026 | |
| 10-Q | Nov 5, 2026 | Nov 5, 2026 | |
| 8-K | Nov 5, 2026 | Nov 5, 2026 | |
| 4 | Nov 3, 2026 | Nov 3, 2026 | |
| 4 | Nov 3, 2026 | Nov 3, 2026 | |
| 4 | Nov 3, 2026 | Nov 3, 2026 | |
| 4 | Nov 3, 2026 | Nov 3, 2026 | |
| 8-K | Oct 16, 2026 | Oct 16, 2026 | |
| SC 13G | Oct 13, 2026 | Oct 13, 2026 | |
| 8-K | Sep 23, 2026 | Sep 23, 2026 | |
| 4 | Sep 3, 2026 | Sep 3, 2026 | |
| 4 | Sep 3, 2026 | Sep 3, 2026 | |
| 3 | Aug 27, 2026 | Aug 27, 2026 | |
| 4 | Aug 27, 2026 | Aug 27, 2026 | |
| 8-K | Aug 25, 2026 | Aug 25, 2026 |
Competitors
Who does REGENXBIO Inc. compete with?
Open similar companies to compare their filings and price history.
Questions
Filing questions
Common questions about RGNX's filings, answered from its disclosures.
What is the latest RGNX filing?
The latest filing shown is SC 13G dated Nov 10, 2026.
How many recent filings does RGNX have?
Intrinsic Alpha currently shows 20 recent filings for RGNX.
Continue the stock analysis
Jump to another research area for this company.